Revino Solutions
HomeCase StudiesAI Manufacturing — US Pharma (3 Plants, 21 CFR)
AI AUTOMATIONPharmaceuticals & BiotechGlobal

AI Manufacturing — US Pharma (3 Plants, 21 CFR)

Batch failure -68% | QC cost -38% | FDA review readiness automated
16 weeks

The Problem We Were Brought In To Solve

US pharma manufacturer: 4.2% batch failure ($2.8M per batch loss), 6-week CAPA cycle, manual QC missing 18% of deviations.

How Revino Delivered

Real-time PAT integration, ML deviation prediction, automated CAPA workflow, 21 CFR Part 11 documentation generation.

Measurable Business Impact

Batch failure: 4.2%→1.35% (-68%)
QC cost: -38%
CAPA closure: -44%
21 CFR activity trail: automated
FDA warning letters: 0
PythonTensorFlowAWS IoTPostgreSQLFastAPIOSIsoft PI
Pharmaceuticals & Biotech IndustryAI Automation & AnalyticsIoT Solutions
KEY METRICS
-68%
Batch failure
-38%
QC cost
-44%
CAPA cycle
0
FDA warning letters
Want results like this?
Free 45-minute consultation — real roadmap, no commitment.
Book Consultation → Contact Us

More Enterprise Results

SAAS & TECHNOLOGY · Global
Technical Staffing — US SaaS Scale-Up (Series B)
8 senior engineers placed in 3 weeks | $480K saved vs agency | 100% retention at 12 months
BANKING & NBFC · India
AI Credit Scoring — India NBFC (₹2,400 Cr Portfolio)
Default -31% | Approval 14 days→4 hours | Thin-file market +38%
BANKING & NBFC · Global
AI Fraud Detection — 3 Global Regional Banks
Fraud -43% | $8.2M recovered Year 1 | False declines -62%

Ready to create your own case study?

Free 45-minute consultation — we discuss your situation, identify the biggest opportunities, and deliver a prioritised roadmap.

Book Consultation → Contact Us